Commercial Portfolio Head Region Europe

Position

Vollzeit

Festanstellung

Senior

Produktmanagement

Konditionen

Basel (City)

CHF 184,800 - 343,200/yr

Anforderungen

10+ J. Erfahrung

Bachelor

EU/EFTA-Bewilligung

Sprachen

Englisch C2

Vergütung

CHF 184,800 - 343,200/yr

Beschreibung

Job Description Summary The Commercial Portfolio Head – Region Europe is accountable for driving performance of mature or in-market brands across the region. The role ensures sustainable revenue, profitability, and lifecycle value through disciplined portfolio management, lifecycle planning, and resource allocation.

Aufgaben

Maximize portfolio performance against revenue and profitability targets
Lead lifecycle management and LOE preparation across markets
Advise on go-to-market strategies and commercial models
Coordinate with cross-functional teams and country organizations
Identify and assess commercial partnership opportunities
Manage governance, due diligence, and approvals for partnerships
Oversee alliance performance, compliance, and issue resolution

Anforderungen

10+ years of commercial experience in pharma
Strong portfolio and lifecycle management expertise
Experience in multi-country or regional roles
Financial acumen and performance management skills
Ability to lead in a matrix organization
Strategic mindset with operational discipline
University degree in life sciences, business, or related field. Advanced degree preferred.
Fluent English required. Additional languages a plus.

Technologien

Agility (Inactive)Asset ManagementBusiness DevelopmentBusiness StrategiesCommercial ExcellenceCross-Functional CollaborationCustomer-OrientedDigital MarketingGo-to-Market StrategiesInfluencing SkillsInspirational LeadershipKey Account ManagementMarket AccessMarketing StrategiesMarket ShareMarket TrendsPeople ManagementProduct LaunchesProduct Lifecycle Management (PLM)Product PositioningProfit and Loss (P&L)Sales

Vorteile

Join Novartis to help reimagine medicine and improve lives.
Work in a collaborative, innovative environment focused on delivering impact at scale.

Unternehmen

Novartis

Pharmaceuticals